Literature DB >> 15159498

Cholesterol and APOE genotype interact to influence Alzheimer disease progression.

R M Evans1, S Hui, A Perkins, D K Lahiri, J Poirier, M R Farlow.   

Abstract

In this retrospective analysis of 443 Alzheimer disease (AD) patients from a 30-week tacrine trial, change in Alzheimer's Disease Assessment Scale score from baseline to final value was significantly associated with a total serum cholesterol/APOE genotype interaction. Disease progression in the no-APOE epsilon4 allele/high-cholesterol subgroup was greater than in the normal-cholesterol subgroups with or without epsilon4. Cholesterol levels and APOE genotype may interact to affect AD progression. The results are consistent with preclinical data on cholesterol's effects in AD.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15159498     DOI： 10.1212/01.wnl.0000125323.15458.3f

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  35 in total

Review 1.  Amyloid-β production: major link between oxidative stress and BACE1.

Authors:  Elena Tamagno; Michela Guglielmotto; Debora Monteleone; Massimo Tabaton
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

2.  Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease.

Authors:  I Masse; R Bordet; D Deplanque; A Al Khedr; F Richard; C Libersa; F Pasquier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

3.  Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba.

Authors:  K Hall; J Murrell; A Ogunniyi; M Deeg; O Baiyewu; S Gao; O Gureje; J Dickens; R Evans; V Smith-Gamble; F W Unverzagt; J Shen; H Hendrie
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

4.  The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system.

Authors:  Scott L Letendre; Jennifer Marquie-Beck; Ronald J Ellis; Steven Paul Woods; Brookie Best; David B Clifford; Ann C Collier; Benjamin B Gelman; Christina Marra; Justin C McArthur; J Allen McCutchan; Susan Morgello; David Simpson; Terry J Alexander; Janis Durelle; Robert Heaton; Igor Grant
Journal:  J Neuroimmune Pharmacol       Date:  2007-01-03       Impact factor: 4.147

Review 5.  Translational research in central nervous system drug discovery.

Authors:  Orest Hurko; John L Ryan
Journal:  NeuroRx       Date:  2005-10

6.  Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study.

Authors:  Archana Singh-Manoux; David Gimeno; Mika Kivimaki; Eric Brunner; Michael G Marmot
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-30       Impact factor: 8.311

7.  The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.

Authors:  Sterling C Johnson; Taylor W Schmitz; Mehul A Trivedi; Michele L Ries; Britta M Torgerson; Cynthia M Carlsson; Sanjay Asthana; Bruce P Hermann; Mark A Sager
Journal:  J Neurosci       Date:  2006-05-31       Impact factor: 6.167

8.  Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers.

Authors:  M S Beeri; M Rapp; J M Silverman; J Schmeidler; H T Grossman; J T Fallon; D P Purohit; D P Perl; A Siddiqui; G Lesser; C Rosendorff; V Haroutunian
Journal:  Neurology       Date:  2006-05-09       Impact factor: 9.910

9.  Gene-environment interaction research and transgenic mouse models of Alzheimer's disease.

Authors:  L Chouliaras; A S R Sierksma; G Kenis; J Prickaerts; M A M Lemmens; I Brasnjevic; E L van Donkelaar; P Martinez-Martinez; M Losen; M H De Baets; N Kholod; F van Leeuwen; P R Hof; J van Os; H W M Steinbusch; D L A van den Hove; B P F Rutten
Journal:  Int J Alzheimers Dis       Date:  2010-10-05

10.  Contribution of vascular risk factors to the progression in Alzheimer disease.

Authors:  Elizabeth P Helzner; José A Luchsinger; Nikolaos Scarmeas; Stephanie Cosentino; Adam M Brickman; M Maria Glymour; Yaakov Stern
Journal:  Arch Neurol       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.